Yayın: Novel asymmetric biscarbothioamides as Alzheimer's disease associated cholinesterase inhibitors: synthesis, biological activity, and molecular docking studies
| dc.contributor.author | BEYDEMİR, ŞÜKRÜ | |
| dc.contributor.author | Hasan Yakan | |
| dc.contributor.author | Musa Erdoğan | |
| dc.contributor.author | Fevzi Topal | |
| dc.contributor.author | Meryem Topal | |
| dc.contributor.author | Cüneyt Türkeş | |
| dc.contributor.author | Şükrü Beydemir | |
| dc.contributor.orcid | 0000-0001-8306-2378 | |
| dc.contributor.orcid | 0000-0002-4428-4696 | |
| dc.contributor.orcid | 0000-0001-6097-2862 | |
| dc.contributor.orcid | 0000-0002-2443-2372 | |
| dc.contributor.orcid | 0000-0002-2107-8603 | |
| dc.contributor.orcid | 0000-0002-2932-2789 | |
| dc.contributor.orcid | 0000-0003-3667-6902 | |
| dc.date.accessioned | 2025-11-13T09:12:05Z | |
| dc.date.issued | 2024-01-01 | |
| dc.identifier.doi | https://doi.org/10.1039/d4nj01462f | |
| dc.identifier.endpage | 10989 | |
| dc.identifier.issn | 1144-0546 | |
| dc.identifier.issue | 24 | |
| dc.identifier.openalex | W4399310491 | |
| dc.identifier.startpage | 10979 | |
| dc.identifier.uri | https://hdl.handle.net/11421/751 | |
| dc.identifier.uri | https://doi.org/10.1039/d4nj01462f | |
| dc.identifier.volume | 48 | |
| dc.language.iso | en | |
| dc.relation.ispartof | New Journal of Chemistry | |
| dc.rights | restrictedAccess | |
| dc.subject | Chemistry | |
| dc.subject | Cholinesterase | |
| dc.subject | Docking (animal) | |
| dc.subject | Butyrylcholinesterase | |
| dc.subject | Pharmacology | |
| dc.subject | Acetylcholinesterase | |
| dc.subject | Biochemistry | |
| dc.subject | Computational biology | |
| dc.subject | Enzyme | |
| dc.subject | Aché | |
| dc.title | Novel asymmetric biscarbothioamides as Alzheimer's disease associated cholinesterase inhibitors: synthesis, biological activity, and molecular docking studies | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5081967794 |
